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Abstract
Background: We provide a re-analysis of the Golden Spike dataset, a first generation "spike-in" control microarray
dataset. The original analysis of the Golden Spike dataset was presented in a manuscript by Choe et al. and raised
questions concerning the performance of several statistical methods for the control of the false discovery rate (across a
set of tests for differential expression). These original findings are now in question as it has been reported that the p-
values associated with the tests of differential expression for null probesets (i.e., probesets designed to be fold change 1
across the two arms of the experiment) are not uniformly distributed. Two recent publications have speculated as to the
reasons the null distributions are non-uniform. A publication by Dabney and Storey concludes that the non-uniform
distributions of null p-values are the direct consequence of an experimental design which requires technical replicates to
approximate biological replicates. Irizarry et al. identify four characteristics of the feature level data (three related to
experimental design and one artifact). Irizarry et al. argue that the four observed characteristics imply that the
assumptions common to most pre-processing algorithms are not satisfied and hence the expression measure
methodologies considered by Choe et al. are likely to be flawed.
Results: We replicate and extend the analyses of Dabney and Storey and present our results in the context of a two
stage analysis. We provide evidence that the Stage I pre-processing algorithms considered in Dabney and Storey fail to
provide expression values that are adequately centered or scaled. Furthermore, we demonstrate that the distributions
of the p-values, test statistics, and probabilities associated with the relative locations and variabilities of the Stage II
expression values vary with signal intensity. We provide diagnostic plots and a simple logistic regression based test
statistic to detect these intensity related defects in the processed data.
Conclusion: We agree with Dabney and Storey that the null p-values considered in Choe et al. are indeed non-uniform.
We also agree with the conclusion that, given current pre-processing technologies, the Golden Spike dataset should not
serve as a reference dataset to evaluate false discovery rate controlling methodologies. However, we disagree with the
assessment that the non-uniform p-values are merely the byproduct of testing for differential expression under the
incorrect assumption that chip data are approximate to biological replicates. Whereas Dabney and Storey attribute the
non-uniform p-values to violations of the Stage II model assumptions, we provide evidence that the non-uniformity can
be attributed to the failure of the Stage I analyses to correct for systematic biases in the raw data matrix. Although we
do not speculate as to the root cause of these systematic biases, the observations made in Irizarry et al. appear to be
consistent with our findings. Whereas Irizarry et al. describe the effect of the experimental design on the feature level
data, we consider the effect on the underlying multivariate distribution of putative null p-values. We demonstrate that
the putative null distributions corresponding to the pre-processing algorithms considered in Choe et al. are all intensity
dependent. This dependence serves to invalidate statistical inference based upon standard two sample test statistics. We
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identify a flaw in the characterization of the appropriate "null" probesets described in Choe et al. and we provide a
corrected analysis which reduces (but does not eliminate) the intensity dependent effects.
Background
Normalization of microarray data is essential for remov-
ing systematic variation and biases that are present due to
the nature of the assay. In experiments where the goal is to
determine differential expression scientists have devel-
oped a variety of tests and algorithms to identify differen-
tially expressed genes. One such experiment was the
"Golden Spike" experiments by [1]. In the experiment six
Affymetrix chips were divided into two groups: a control
group (C) and a spike group (S). The S sample contains
the same cRNAs as the C sample, except for ten selected
groups of approximately 130 cRNAs per group that are
present at a defined increased concentration compared to
the C sample. This results in 3860 cRNAs, where 1309
cRNAs are spiked in with differing concentrations
between the S and C samples. The rest (2551) are present
at identical relative concentration between the two sets of
microarrays. This type of experiment models the general
paradigm of experiments meant to detect differential
expression. Recently, however, the validity of inference
based upon the Golden Spike experiment has been ques-
tioned [2].
A key component to the Golden Spike dataset is knowl-
edge of the null p-values for tests of differential expres-
sion, that is, information of the genes that are present in a
1:1 ratio on the S chips and the C chips provides knowl-
edge of which tests for differential expression are truly
null. Figure 1 provides a schematic of the two stage proce-
dure used to obtain the sets of null p-values referenced in
[1] and [2]. The raw Golden Spike dataset consists of data
generated by the scanning device used to measure the rel-
ative spot fluorescence values across each microarray chip.
For oligonucleotide (Affymetrix) experiments such as the
Golden Spike, the nature of the design demands heavy
statistical intervention.
In microarray experiments, the end-stage analysis usually
consists of simple two-sample test statistics such as the t-
statistic or the Wilcoxon Rank Sum test statistic to test for
differential expression. However, it is important to note
that these statistics generally operate upon data matrices
which have been subjected to potentially significant
amounts of pre-processing. With this technology, there
are several steps required in order to process the data in
order to achieve a single value representing the intensity
for a given probe. It is worthwhile to consider the Affyme-
trix data acquisition in two stages. A Stage I analysis
includes image processing where each spot is deemed to
consist of a collection of pixels. From the collection of pix-
els at a spot an overall signal value is determined by taking
a summary measure (often a median) of the pixel set at
each hybridization location on the chip. In the Affymetrix
data design there are 11 probe pairs spotted for each gene
or SNP. Each probe pair contains two 25-mer DNA oligo-
nucleotide probes; the perfect match (PM) probe matches
perfectly to the target RNA, and the mismatch (MM)
probe which is identical to its PM partner probe except for
a single homomeric mismatch at the central base-pair
position. The MM probe serves to estimate the nonspecific
signal. In this stage, the PM and MM signals are combined
into one score representing the expression signal for a spe-
cific probe. The major software packages for Stage I analy-
sis include Bioconductor's "Affy" package, dChip and
MAS 5.0 executables [1]. Each software package varies in
how the image processing is performed and how the PM
and MM values are combined. After obtaining a signal for
each probe, the next step in the Stage I analysis is to "nor-
malize" the data accounting for between chip effects, spa-
tial effects, intensity effects, a possible grid effect, and any
nonlinear intensity/variation effects. Popular normalizing
methods include lowess and loess smoothers to remove
systematic sources of noise [3,4].
The Stage I analysis often involves a matrix of dimension
p by m where the p rows refer to the different probes, and
the m columns refer to the different chips. The general
procedure in normalizing this data is to use loess smooth-
ers on the data set. One of the motivations for the Golden
Spike experiment was to examine the numerous and var-
ied normalization methods that currently exist for this
data. Most of the normalization methods consider the
data as a function of the matrix column. The goal of any
of these normalization schemes is to reduce the systematic
variation that exists in each chip. By considering each col-
umn of the data matrix as a separate chip, in each column
we can scale and center the values, via loess smoothers so
that each column has roughly the same "center" and
"scale." This general approach (as discussed in [3]) does
not deal well with nonlinear relationships between arrays.
Another method from [3] is to transform the data via
quantile regression so that the distribution of probe inten-
sities is roughly the same across arrays. At this stage, the
normalization should result in a dataset where the sys-
tematic variation is reduced in order to get a clearer
glimpse of the biological variatio that is present in these
experiments.
Ultimately, the Stage I analysis results in an X matrix of
dimension p by m for each experiment where the p rowsBMC Genomics 2007, 8:105 http://www.biomedcentral.com/1471-2164/8/105
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correspond to each (smoothed) probe value and the m
columns correspond to the sample. In the Golden Spike
datasets, numerous options in the Stage I analysis were
examined, resulting in 152 different X matrices with each
matrix corresponding to a different set of parameters in a
Stage I analysis. From these 152 datasets, 10 "best" data-
sets were chosen that represented the best combination of
processing in terms of detecting approximately 95 percent
of true differentially expressed genes (DEGs) with changes
greater than twofold, but less than 30 percent with
changes below 1.7 fold before exceeding a 10 percent
false-discovery rate. At this point, each data matrix X rep-
resents the input for Stage II analysis. The goal of Stage II
analysis is to answer the researcher's questions of the
experiment. Usually in the microarray setting this consists
of a ranked list of genes determined to be differentially
expressed between two groups such as treatment versus
control. The methods of Stage II generally take in to
account facets of the experimental design and allow the
user to control for things like the false discovery rate
(FDR) within a given two sample test environment. Often
the validity of Stage II analyses depends upon the assump-
tion that the Stage I analysis has provided a Stage II data
matrix such that the two sample test statistic null p-values
are uniformly distributed.
Dabney and Storey [2] provide a re-analysis of the Golden
Spike dataset in which they consider the most common
choices for the Stage II analysis (e.g., t-test, permutation t-
test, and Wilcoxon Rank Sum test) and demonstrate that
the null p-values for the Choe et al. 10 best datasets were
non-uniform in all cases. The authors note that statistical
methods to control the FDR require the assumption that
the true null p-values are uniformly distributed and hence
the Golden Spike data can not be utilized to assess the per-
formance of such methods. Furthermore, Dabney and
Storey conclude that the non-uniform distributions of p-
values are the direct consequence of an experimental
design which requires that technical replicates adequately
approximate biological replicates. The authors provide
simulation results which demonstrate that technical repli-
cates analyzed as biological replicates can provide non-
uniform null p-value distributions but fail to provide any
evidence that the parameter values that evoke this behav-
ior are consistent with the set of conditions under which
the Golden Spike experiment was conducted. Presumably
the reader is left to infer that because the null p-values are
non-uniform and because technical replicates analyzed as
biological replicates can provide non-uniform null distri-
butions, then the technical replicates generated by the
Golden Spike experiment do not adequately approximate
biological replicates.
We have replicated and extended the analyses of Dabney
and Storey and we agree with the assessment that the null
p-values are indeed non-uniform. We also agree with the
conclusion that, given current pre-processing (i.e., Stage I)
technologies, the Golden Spike datasets should not serve
as reference datasets to evaluate FDR controlling method-
ologies. However, we disagree with the assessment that
the non-uniform p-values are merely the byproduct of
testing for differential expression under the assumption
that chip data are approximate to biological replicates
when, in fact, they are not. Whereas Dabney and Storey
attribute the non-uniform p-values to violations of the
Stage II model assumptions, we provide evidence that the
non-uniformity can be attributed to the failure of the
Stage I analyses to correct for systematic biases in the raw
data matrix.
A recent article by Irizarry et al. [5] identifies four charac-
teristics of the feature level data (three related to experi-
mental design and one artifact) which offer a possible
explanation for the inconsistencies between the conclu-
sions presented in [1] and [6]. Irizarry et al. argue that the
four observed characteristics imply that the assumptions
common to most pre-processing algorithms are not satis-
fied and hence the expression measure methodologies
A two-stage procedure was used to obtain the sets of null p- values referenced in [1] and [2] Figure 1
A two-stage procedure was used to obtain the sets of null p-
values referenced in [1] and [2]. The first stage of the proce-
dure involves the application of algorithms designed to cor-
rect and normalize the raw data matrix, W. The second 
stage of the procedure involves the evaluation of a test statis-
tic for differential expression using information from the 
Stage II data matrix, X. [1] considered 150+ unique combina-
tions of algorithms and input parameter values for the Stage I 
analysis and proposed a subset of the 10 best. [2] determined 
that the distributions of the null p-values for the [1] 10 best 
Stage I analyses were non-uniform for the most common 
choices for the Stage II analysis (e.g., t-test, permutation t-
test, and Wilcoxon Rank Sum test). [2] concluded that this 
non-uniformity implies that the technical replicates generated 
by the experiment do not constitute adequate approxima-
tions of biological replicates and hence, the Stage II model 
assumptions associated with these tests are not met. We 
provide evidence that the non-uniformity can be attributed, 
at least in part, to the failure of the Stage I analyses to cor-
rect for systematic biases in the raw data matrix, W.BMC Genomics 2007, 8:105 http://www.biomedcentral.com/1471-2164/8/105
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considered in [1] are likely to be flawed. Whereas Irizarry
et al. describe the effect of the experimental design on the
feature level data, we consider the effect on the underlying
multivariate distribution of putative null p-values. Specif-
ically, we demonstrate that the 10 best Stage I analyses
considered in [1] and [2] provide Stage II data matrices in
which the columns are neither adequately centered nor
adequately scaled. Further we note that the observed devi-
ations in centering and scaling are intensity dependent.
The intensity dependence of the Stage II data values leads
to putative null distributions which are intensity depend-
ent and hence non-uniform. We provide simple diagnos-
tic plots which indicate that the relative center and scales
of the underlying distributions for the control and spike-
in expression values vary as a function of signal intensity.
Although the scope of this manuscript is in large part
restricted to the re-analysis of the Golden Spike dataset,
we also apply several of the same diagnostic plots to
another Affymetrix spike-in experiment. The results sug-
gest that some of the intensity dependent effects may exist
in other settings. We relegate the extensive application
and the continued development of such diagnostics to
future research.
Results and Discussion
Re-analysis of the Golden Spike Dataset
Our analysis of the Golden Spike Dataset reveals that the
null two sample t-test p-value distributions are non-uni-
form across the 152 combinations of Stage I analyses. The
fact that all distributions were non-uniform implies that
this problem can not be attributed to the procedure uti-
lized to identify the ten best datasets. The two sample test
was conducted using the equal variance t-test so that the
analysis would be consistent with the one presented in
[2]. Other test statistics (i.e., Wilcoxon Rank Sum, permu-
tation t-test, and Welch's t-test) were considered and
yielded similar results, a finding which is also consistent
with those reported in [2]. Figure 2 contains sample quan-
tile plots for the 152 sets of null p-values corresponding to
the 152 datasets described in [1]. The black curves in Fig-
ure 2(a) correspond to the ten best datasets (i.e., datasets
labeled 9a-e and 10a-e). The grey curves in Figure 2(a) cor-
respond to the remaining 142 datasets and demonstrate
that non-uniform null p-values were observed in datasets
other than the ten best.
Observed p-value Distributions Inconsistent with Model of Dabney 
and Storey
Dabney and Storey attributed the non uniform distribu-
tion of p-values to the fact that the Golden Spike experi-
mental design requires technical replicates to masquerade
as biological replicates. In their response to [2], the
authors of [1] acknowledged that the three spike-in and
three control chips were technical replicates but they
argued that the differences in the relative concentrations
of the fold change one genes within the master spike-in
sample (i.e., prior to splitting into three samples) com-
pared to those in the master control sample should have
had a negligible impact on the observed expression val-
ues.
Dabney and Storey proposed the following model for i
genes, i = 1, 2,...m, j treatments, j = C,S and k technical rep-
licates, k = 1, 2, 3 and the Stage II expression data matrix X:
Xijk = μij + εij + φijk (1)
where
and φijk~N (0,  ). In the model stated in Equation (1),
straightforward calculations show that for gene i we have
the following distribution:
If we consider the linear combination:
where  iS, and  iC represent the sample mean for probe
i under condition S and C, respectively, then it follows
that
The standard two-sample t-statistic is given by
where sS and sC represent the sample standard deviation of
probe i under condition S and C respectively. It follows
from (3) that a t-test statistic calculated with respect to
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random variables governed by model (1) constitutes an
observation from a distribution which is heavier in the
tails than a t4 distribution provided 2(1 - ρ) > 0. This
follows from the fact that square of the denominator of
the test statistic is an unbiased estimator of   and
hence, a negatively biased estimator of the variance of Wi.
Hence, evaluating t-test statistics such as (4) against a t4
distribution will provide p-values which are negatively
biased. This is the crux of the Dabney and Storey critique
of the Golden Spike experimental design. Unfortunately
the experimental design does not provide enough data to
fit model (1) and directly estimate the relative magnitudes
σi
2
2
3
2 τi
Sample quantile plots for various sets of null p- values Figure 2
Sample quantile plots for various sets of null p- values. The x-axes correspond to the expected quantiles for a uniform distribu-
tion and the y-axes correspond to the observed (sample) quantiles. (a) Sample quantile plots for the t-test p-values associated 
with the 152 preprocessing combinations described by [1]. Black lines correspond to the 10 best datasets and are consistent 
with the curves presented in Figure 1 of [2]. The red lines correspond to re-loessed datasets that were obtained using the 
same combinations of preprocessing steps as the original 10 sets with the exception that the invariant subsets consisted only of 
the "present null" (present with fold change = 1) probesets (versus both the "present null" and "empty null" probesets used in 
[1]). The distribution of the p-values thus depends upon the choice of the invariant subset. (b) Sample quantile curves for data-
set 10a. Solid lines correspond to the two-sided p-values and the dashed and dotted lines correspond to the p-values associ-
ated with the one sided tests. The model presented in [2] does not account for the discrepancy in the one-sided p-values 
observed for this dataset, which is not manifest in the re-loessed data (red lines). Similar results are seen with datasets 10b, c, 
d and 9a, b, c, d. (c) As in (b) but showing sample quantile curves for dataset 10e; dataset 9e is similar. The p-value discrepan-
cies are much less pronounced for these two datasets. This figure appears with permission in the response to [2].
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of   and  . However, it is still possible to determine
that model (1) does not adequately explain all aspects of
the observed p-value distributions for all Stage II datasets.
There is an underlying symmetry to this putative model
mis-specification because if the t-test statistic underesti-
mates the actual variance, then the distributions of the
one-sided p-values should be parsimonious with the dis-
tribution of the two-sided p-values. In actuality, the one-
sided p-values for eight of the ten best datasets proved to
be inconsistent with the two sided p-values. Figure 2(b)
contains the sample quantile curves for dataset 10a where
solid lines correspond to the two-sided p-values and the
dashed and dotted lines correspond to the p-values asso-
ciated with the one sided tests. The distributions of the
one-sided p-values are not in agreement. Surprisingly, the
set of p-values associated with the "less than" alternative
appearing to contain a disproportionate number of large
p-values and an insufficient number of small p-values.
Datasets 9a-d and 10b-d provided results similar to those
observed for dataset 10a. Figure 2(c) contains the sample
quantile curves for dataset 10e in which the two sets of
one-sided p-values appear to share the same underlying
distribution.
Most importantly, the model (1) does not adequately
explain the most intriguing aspect of the observed p-value
distributions for all Stage II datasets; that the distributions
are not invariant with respect to the overall signal inten-
sity. Figures 3(a) and 3(c) contain curves which estimate
the underlying population quartiles for the p-value distri-
butions as a function of signal intensity for datasets 10a
and 10e. The observed p-values were modeled as a func-
tion of a 4th  order polynomial for rankit intensity,
. The curves were fit using quantile
regression [7,8] where the black lines correspond to the
fits for τ = 0.5 (solid) and τ = 0.25, 0.75 (dashed). Solid
and dashed grey lines indicate the theoretical medians
and quartiles, respectively. Inspection of Figure 3(a)
reveals that the p-values for dataset 10a are negatively
biased across all intensities but that the magnitude of the
bias is intensity variant. Inspection of Figure 3(b) reveals
that the p-values for dataset 10e are also negatively biased
across all intensities but that the magnitude of the bias
does not vary with intensity to the extent which was
observed for dataset 10a. Figures 4(a) and 4(c) contain
curves which estimate the underlying population quar-
tiles for the t-test distributions as a function of signal
intensity for datasets 10a and 10e. As in the previous fig-
ure, the observed t-tests were modeled as a function of a
4th order polynomial for rankit intensity. The curves were
fit using the quantile regression and are coded as in Fig-
ures 3(a) and 3(c). For dataset 10a, the test statistics cor-
responding to the null genes with overall signal intensities
falling below the median all appear to be positively biased
and exhibit a greater degree of variation than is compati-
ble with the null t4 distribution. This observation is con-
sistent with the previous observation that the p-values
associated with the "less than" alternative contain an
excessive number of large p-values. For dataset 10e, the
test statistics corresponding the null genes with overall
signal intensities falling in the lower 15–20% appear to be
negatively biased while test statistics corresponding the
null genes with overall signal intensities falling in the
upper 15% appear to be positively biased. The results in
Figures 2(c) and 4(c) suggest that the effect that these
biases have upon the relative distributions of the one-
sided p-values appears to wash out across all signal inten-
sities even though the distributions are different for genes
with overall signal intensities at the extremes.
Re-Loessing Golden Spike Dataset Improves Null Distributions
Each of the ten best Choe et al. Stage II data matrices were
obtained using Stage I steps that included correcting the
observed intensity with a loess curve that was fit to values
from an invariant set of genes. This invariant set included
present null (i.e., present with a putative fold change of
one) as well as empty null (i.e., not present in either sam-
ple) probesets. The inclusion of the empty null probesets
appears to have had a deleterious effect on the distribu-
tions of the null p-values. We have calculated a new set of
ten best datasets in which the invariant set contains only
the present null probesets. These calculations were per-
formed at our request by the authors of [1] using analysis
scripts which were identical to those used for the original
analyses except for passages of the code relating to the
identification of the invariant set. The red curves in Fig-
ures 2(a)–(c) correspond to the sample quantile curves for
the re-loessed datasets. The "re-loessed" datasets are still
significantly non-uniform, although noticeably less so
than the original datasets. Inclusion of the empty nulls in
the original invariant sets appears to have contributed to
the observed biases in the underlying t-distributions as
inspection of Figures 4(b) and 4(d) indicates that this bias
appears to be mitigated in the re-loessed datasets.
Other Common Two Sample Tests Failed to Provide Uniform Null 
Distributions
Although removal of the empty nulls from the invariant
set provides data that is better centered than the original
ten best, the results depicted in Figures 3(b) and 3(d) indi-
cate that the p-value distributions are still non-uniform
σi
2 τi
2
rank of value
total of values # +1BMC Genomics 2007, 8:105 http://www.biomedcentral.com/1471-2164/8/105
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and intensity dependent. We re-analyzed the re-loessed
ten best datasets using three other common two sample
test procedures and found that none were robust to the
problems which remain in the underlying Stage II data
matrices. Figure 5 contains the results of this analysis for
re-loessed dataset 10a.
Distribution Free Diagnostic Plots
A distribution free analysis of the ten best datasets (origi-
nal and re-loessed) reveals that removal of the empty nulls
from the invariant set provides for Stage II datasets which
are adequately centered but inadequately scaled. We
(loosely) refer to the analysis as distribution free because
it does not include distributional assumptions associated
with a test statistic. The adequacy of the centering and
scaling of the data is, of course, relative. The re-loessed
data appears to be adequately centered in that the proba-
bility that randomly selecting a null probeset such that the
average expression value for the control samples is larger
than that for the spike-in samples is approximately one
Estimates of the null p-value quartiles vary as a function of signal intensity for datasets 10a (a, b) and 10e (c, d); although less so  for the re-loessed data Figure 3
Estimates of the null p-value quartiles vary as a function of signal intensity for datasets 10a (a, b) and 10e (c, d); although less so 
for the re-loessed data. The x-axes correspond to the rankit (i.e.,  ) of the log of the product of the 
expression means. The y-axes correspond the observed two-sided p-values. Solid and dashed grey lines indicate the theoretical 
medians and quartiles, respectively. The null p-values were modeled as a function of a 4th order polynomial for rankit intensity. 
Black and red lines correspond to the quantile regression fits for τ = 0.5 (solid) and τ = 0.25, 0.75 (dashed). Portions of this fig-
ure appear with permission in the response to [2].
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half regardless of the overall signal intensity. The re-
loessed data appears to be inadequately scaled in that the
probability that randomly selecting a null probeset such
that the variation in the expression values for the control
samples is larger than that for the spike-in samples is less
than one half. Further this variation is dependent on the
overall signal intensity. Figure 6 contains a panel of distri-
bution free diagnostic plots to assess the adequacy of the
centering and scaling of spike-in experiment (i.e., where
true null fold changes are known) Stage II data. To evalu-
ate relative centering, we propose modeling the probabil-
ity that, for a randomly sampled probeset, the control
samples will have a median expression value greater than
the matched spike-in samples using the logit of a 4th order
polynomial for rankit intensity. To evaluate relative scal-
ing, we propose modeling the probability that, for a ran-
domly sampled probeset, the control samples will have a
median absolute deviation (MAD) greater than the
Estimates of the null t-test statistic quartiles vary as a function of signal intensity for datasets 10a (a, b) and 10e (c, d); although  less so for the re-loessed data Figure 4
Estimates of the null t-test statistic quartiles vary as a function of signal intensity for datasets 10a (a, b) and 10e (c, d); although 
less so for the re-loessed data. The x-axes correspond to the rankit (i.e.,  ) of the log of the product of the 
expression means. The y-axes correspond the observed two-sided t-test statistics. Solid and dashed grey lines indicate the the-
oretical medians and quartiles, respectively. The null t-test statistics were modeled as a function of a 4th order polynomial for 
rankit intensity. Black and red lines correspond to the quantile regression fits for τ = 0.5 (solid) and τ = 0.25, 0.75 (dashed). 
The overwhelming positive deviation of the null distribution in (a) is consistent with the discrepancy between the one-sided p-
values observed in Figure 2(b). Portions of this figure appear with permission in the response to [2].
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matched spike-in samples using the logit of a function of
a 4th order polynomial for rankit intensity. Given that
there were only three replicates in the Golden Spike data-
set we used the average of the two absolute deviations
from the median value in place of the more common for-
mulation of the MAD (which would have provided only
the minimum of the two non-zero absolute deviations).
The curves presented in Figure 6 correspond to the logistic
regression fitted values. Note that the curves correspond-
ing to the relative centering of the expression values (solid
lines) are consistent with the biases observed in the t-sta-
tistics (depicted in Figure 4).
Estimates of the null p-value quartiles vary as a function of signal intensity for four common two sample test procedures applied  to the re-loessed dataset 10a Figure 5
Estimates of the null p-value quartiles vary as a function of signal intensity for four common two sample test procedures applied 
to the re-loessed dataset 10a. The x-axes correspond to the rankit (i.e.,  ) of the log of the product of the 
expression means. The y-axes correspond the observed two-sided p-values. Solid and dashed grey lines indicate the theoretical 
medians and quartiles, respectively. The null p-values were modeled as a function of a 4th order polynomial for rankit intensity. 
Red lines correspond to the quantile regression fits for τ = 0.5 (solid) and τ = 0.25, 0.75 (dashed). (a) P-values for the two sam-
ple t-test conducted under the assumption of equal variances. (b) P-values for the two sample t-test conducted under the 
assumption of unequal variances (a.k.a. Welch's test). Relaxing the assumption of equal variances provides for only a slight 
improvement in the distribution of the null p-values (c) P-values for the Wilcoxon Rank Sum test. (d) P-values for the permuta-
tion test [19,20]. Permutation based approaches are not robust to the systematic errors manifest in the Stage II data matrix.
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 (a) t−test
rankit log( c s)
p
−
v
a
l
u
e
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 (b) Welch’s t−test
rankit log( c s)
p
−
v
a
l
u
e
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 (c) Wilcoxon Rank Sum test
rankit log( c s)
p
−
v
a
l
u
e
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0 (d) Permutation test
rankit log( c s)
p
−
v
a
l
u
e
rank of value
total of values # +1BMC Genomics 2007, 8:105 http://www.biomedcentral.com/1471-2164/8/105
Page 10 of 16
(page number not for citation purposes)
Table 1 contains results which indicate that the removal of
the empty nulls from the invariant set provides for Stage
II datasets which are adequately centered but are still inad-
equately scaled. For each of the 20 datasets considered,
logistic models were fit as described above (i.e., the appro-
priate probability was modeled as the logit of a 4th order
A diagnostic plot to assess, as a function of signal intensity, whether or not the underlying distributions for the control and  spike-in expression values share the same center and scale Figure 6
A diagnostic plot to assess, as a function of signal intensity, whether or not the underlying distributions for the control and 
spike-in expression values share the same center and scale. The x-axes correspond to the rankit (i.e.,  ) of 
the log of the product of the expression means. The y-axes correspond the probability that the control samples will have a 
value greater than the spike-in sample; values for the median and the MAD (median absolute deviation) were considered. The 
horizontal solid gray line corresponds to a probability of  . The probability that, for a randomly sampled probeset, the con-
trol samples will have a value greater than the matched spike-in samples was modeled as the logit of a 4thorder polynomial for 
rankit intensity. Solid (dashed) lines correspond to the logistic regression fits for the median (MAD). Diagnostic plots (a) and 
(c) indicate that, prior to re-loessing, the control and spike-in expression values were not equivalently centered and scaled for 
all signal intensities. Diagnostic plots (b) and (d) indicate that re-loessing the data provided control and spike-in expression val-
ues which were equivalently centered and but not equivalently scaled. Although loess correcting using only the set of true 
invariants can provide Stage II data which is adequately re-centered, issues pertaining to relative scale may remain and can inval-
idate the null distributions of commonly used two sample test statistics.
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polynomial for rankit intensity) and were tested against a
null model that the appropriate probability was constant
with respect to rankit intensity. The deviances and asymp-
totic p-values (in bold) are reported. Given the possibility
for cross hybridization of probesets, the assumption that
the observed expression values are independent is dubi-
ous, although less tenuous than in a non-controlled
experiment. The p-values, albeit approximate, indicate
that the relationship between relative centering and inten-
sity is highly significant in the original datasets and insig-
nificant at a marginal level of 0.05 for all re-loessed
datasets save 10e. The tabulated results indicate that the
relationship between relative variability and intensity is
highly significant for all datasets. However, the deviance
values are significantly improved for several re-loessed
datasets, most notably 10a-d.
A set of diagnostic plots were created to assess whether the
differences in relative centering and variability could be
attributed to a one or two rogue samples. Figure 7
includes an example panel of the diagnostic plots for sam-
ple datasets 10a and 10e. These plots constitute a varia-
tion on the theme of the plots presented in Figure 6. The
probability that a given sample will have an expression
value greater than the median of the expression values for
the balance of samples was modeled as the logit of a 4th
order polynomial for rankit intensity. Inspection of Fig-
ures 6(a) and 6(c) reveal that the within subpopulation
(i.e., control and spike-in) logistic model fits are remarka-
bly consistent for dataset 10a and are less so for dataset
10e. None of the plots support the hypothesis that a
minority of the samples (i.e., one or two samples) are
wildly inconsistent with the majority.
Diagnostic Plots Applied to the Affymetrix SpikeInSubset 
Data
Diagnostic plots were created for the Affymetrix "SpikeIn-
Subset" data contained in the Bioconductor [9] SpikeIn-
Subset [10] package. The experiment was part of a larger
experiment consisting of a series of transcripts spiked-in at
known concentrations and arrayed in a Latin Square for-
mat. Figures 8 and 9 contain results for a six array subset
(2 sets of triplicates) of the original experiment. Specifi-
cally, diagnostic plots were created for the stage II datasets
created by the application of the RMA, threestep, and MAS
preprocessing algorithms to the raw data.
Figure 8 suggests that the null distributions may be inten-
sity dependent, although not to the extent as was observed
in the original Golden Spike datasets. This result is
expected as the Affymetrix SpikeInSubset experiment con-
tained a smaller quantity of spiked in transcripts and did
not contain anomalies of the type described in [5]. Figure
9 suggests that the intensity dependence is most notable
at the extremes and that the relative variability of the
expression values appears to be intensity dependent when
the data is normalized using the RMA algorithm.
This analysis does not constitute a thorough investigation
of the suitability of the SpikeInSubset data for validation
of FDR estimation techniques. Unlike the Golden Spike
data set, only a few naive "out of the box" algorithms were
Table 1: Results of logistic regression for intensity dependence. 
Median MAD
dataset original re-loess original re-loess
9a 184 (8.23e-39)4 . 3 7 ( 0.358)8 1 . 5 ( 8.28e-17)6 2 . 6( 8.26e-13)
9b 246 (5.02e-52) 3.2 (0.525)4 8 . 1 ( 9.06e-10)4 9 . 9( 3.79e-10)
9c 225 (1.56e-47)3 . 4 1 ( 0.492)8 3 . 4 ( 3.26e-17)6 2 . 3 ( 9.6e-13)
9d 271 (1.85e-57)4 . 0 2 ( 0.403)7 1 . 7 ( 9.93e-15)5 9( 4.73e-12)
9e 104 (1.28e-21)7 . 6 1 ( 0.107)2 4 . 2 ( 7.38e-05)4 5 . 3( 3.37e-09)
10a 151 (1e-31)6 . 6 1( 0.158)8 2 . 3 ( 5.69e-17)3 5 . 6( 3.47e-07)
10b 190 (4.86e-40)3 . 1 9 ( 0.527)1 0 2 ( 4.63e-21)3 2 . 5( 1.54e-06)
10c 214 (4.52e-45)8 . 1 2 ( 0.0874)1 2 4 ( 6.76e-26)4 7 . 7( 1.11e-09)
10d 238 (2.1e-50)4 . 6 2 ( 0.329)1 5 7 ( 6.06e-33)3 9 . 4( 5.63e-08)
10e 105 (8.49e-22)1 2 ( 0.0171)2 1 . 9 ( 0.000208)3 6 . 4( 2.43e-07)
The probability that the control samples will have a value greater than the matched spike-in samples was modeled as the logit of a function of a 4th 
order polynomial for rankit intensity. Values for the median and the MAD (median absolute deviation) were considered. The deviances and p-values 
(in bold) for the comparison of the polynomial model to a constant null model are provided and are consistent with the results presented in Figure 
6. Re-loessing the data using only the fold change 1 all but eliminates the relationships between intensity and relative centering of the two sample 
populations. However, the relationships between intensity and relative variability of the expression values remain, although they are greatly 
diminished.BMC Genomics 2007, 8:105 http://www.biomedcentral.com/1471-2164/8/105
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applied to the raw data (rather than an analysis which
spans many possible combinations and settings). Figures
8 and 9 have been included to illustrate that the diagnos-
tic plots can detect differences between (and possible
defects within) the underlying putative null distributions
associated with different normalization procedures. These
figure also highlight the need for the development of for-
mal methods to assess the statistical significance of such
results.
A diagnostic plot to assess, as a function of signal intensity, whether or not the underlying distributions for the expression val- ues from each chip/sample share the same center Figure 7
A diagnostic plot to assess, as a function of signal intensity, whether or not the underlying distributions for the expression val-
ues from each chip/sample share the same center. The x-axes correspond to the rankit (i.e.,  ) of the log 
of the product of the expression means. The y-axes correspond the probability that the observed expression value for a given 
sample will exceed the median of the expression values for the samples not under direct examination. The horizontal solid gray 
line corresponds to a probability of  . The probability that the sample under consideration will have an 
expression value greater than the median of the expression values for the samples not under direct examination, was modeled 
as the logit of a 4th order polynomial for rankit intensity. Colored lines correspond to the logistic regression fit values. The 
within subpopulation logistic model fits are remarkably consistent for dataset 10a and are less so for dataset 10e. Plots (a) and 
(b) suggest that problems with relative centering can not be attributed to one or two "outlying" samples. Rather, these plots 
support the hypothesis that the Stage I pre-processing algorithms could not adequately adjust for differences in the underlying 
population distributions of the expression values for the empty probesets.
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Conclusion
The Golden Spike dataset was generated to address a
dearth of controlled spike-in array datasets. The original
analysis of the data was presented in [1] and concluded,
among other things, that common methods to control the
false discovery rate had failed to control at the nominal
level. Dabney and Storey determined that the failure of
the FDR algorithms was not methodological, rather the
distributions of the null p-values corresponding to the
most common choices for the Stage II analysis (e.g., t-test,
permutation t-test, and Wilcoxon Rank Sum test) were
non-uniform for the datasets which were considered.
Estimates of the null t-statistic and p-value quartiles vary as a function of signal intensity for the Affymetrix SpikeInSubset data- set Figure 8
Estimates of the null t-statistic and p-value quartiles vary as a function of signal intensity for the Affymetrix SpikeInSubset data-
set. The dataset was processed using Bioconductor implementations of the RMA, MAS, and three-step normalization functions. 
The x-axes correspond to the rankit (i.e.,  ) of the log of the product of the expression means. The y-axes 
correspond to the observed t-test statistics and the observed two-sided p-values for the top and bottom rows, respectively. 
Solid and dashed grey lines indicate the theoretical medians and quartiles, respectively. The null p-values and t-statistics were 
modeled as a function of a 4th order polynomial for rankit intensity. Black and red lines correspond to the quantile regression 
fits for τ = 0.5 (solid) and τ = 0.25, 0.75 (dashed). The plots suggest that the null distributions may be intensity dependent, 
although not to the extent as was observed in the original Golden Spike datasets. Accurate quantification of the statistical sig-
nificance associated with the observed intensity dependence requires an understanding of the underlying correlation structure 
across expression measures and remains an open research question.
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Dabney and Storey concluded that the Stage II model
assumptions (e.g., that the denominator of t-test is appro-
priate estimator of the underlying variation) associated
with these tests are not met, as the non-uniform p-value
distributions imply that the technical replicates generated
by the experiment do not constitute adequate approxima-
tions of biological replicates. We note that their simula-
tion parameters are provided without justification and we
demonstrate that their model is inconsistent with the
observed p-value distributions. In demonstrating that
their analysis is flawed, we conclude that the adequacy of
the technical/biological replicate approximation remains
an open research question. Such a result has relevance
with respect to the design of future spike-in experiments.
We suspect that the underlying null distributions are
adversely effected by failures of the normalization algo-
rithms to properly account for the abnormal feature level
characteristics identified by [5]. While Irizarry et al. spec-
ulate that the Golden Spike data may not be appropriate
for the comparison of methods for FDR control, we con-
firm that this is the case and we demonstrate the failure of
the Stage I analyses to correct for systematic biases (what-
ever their cause may be) in the raw data matrix.
Our analysis of the Golden Spike data also reveals that the
invariant set of genes used for the pre-processing steps in
Choe et al. should not have included the empty null
probesets. We demonstrate that removing the empty
probesets from the invariant set can provide Stage II data
Diagnostic plots applied to the Affymetrix SpikeInSubset dataset Figure 9
Diagnostic plots applied to the Affymetrix SpikeInSubset dataset. Axes for the top row of plots are as described in Figure 6. 
Axes for the bottom row of plots are as describes in Figure 7. The relative variability of the expression values appears to be 
intensity dependent when the data is normalized using RMA. Plots (d), (e), and (f) suggest that the intensity dependence is most 
notable at the extremes.
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which appears to be adequately re-centered, a result which
is dependent upon artificial knowledge of the true invari-
ant set. Unfortunately, even under these ideal conditions,
issues pertaining to higher moments (e.g., relative scale)
remain and these issues appear to invalidate the null dis-
tributions of commonly used two sample test statistics.
Our analysis constitutes proof of principle that the distri-
butions of the p-values, tests statistics, and probabilities
associated with the relative locations and variabilities of
the expression values can vary with signal intensity. This
implies that Stage I algorithms do not always adequately
adjust for intensity dependent effects. If the variation of
the expression values for the null genes is a consequence
of the unbalanced design of the experiment, then it is rea-
sonable to speculate the existence of biological conditions
which could engender similar imbalances. For example,
such imbalances could occur when comparing different
tissue types, in cases of immune challenge or in certain
developmental time course studies. Although it remains
an open research question whether our findings apply to
other datasets we note the assessment by Irizarry et al. that
experiments for which normalization assumptions do not
hold are becoming more common.
If the diagnostics which we have introduced prove useful
for other datasets, then questions of optimality must be
considered. For example, one of the diagnostic tests was
based upon a 4th order polynomial logistic regression
model. The order and nature of the model were chosen for
computational convenience. A higher order model or a
spline based approach could conceivably provide an
improved diagnostic. However, the properties of the diag-
nostic are dependent on the unknown multivariate distri-
bution of the feature level values for invariant genes. In
order to compare statistical tests for intensity dependence
of the p-values we would need to characterize the multi-
variate distribution of the invariant probes. This is very
difficult due to the complicated correlation structure
among the probes (e.g., correlations due to cross hybridi-
zation); a correlation structure that may vary from experi-
ment to experiment. Thus the task of optimizing the
diagnostics is fraught with challenges and has been rele-
gated to future research.
Methods
The Golden Spike dataset was generated according to the
experimental design described in [1] and clarified in Fig-
ure 5 of [2]. The Golden Spike data was "re-loessed" using
an invariant set which only contained the present null
probesets. These calculations were performed at our
request by the authors of [1] using analysis scripts which
were identical to those used for the original analyses
except for passages of the code relating to the identifica-
tion of the invariant set. All calculations and figures pre-
sented in this manuscript were conducted using the R
language and environment [11].
The Affymetrix "SpikeInSubset" data is contained in the
Bioconductor [9] SpikeInSubset package [10]. The RMA
[12,13], threestep, and MAS 5.0 [14] methods were
applied using functions available in the "affy" [15] and
"affyPLM" [16] R packages. When using the threestep pro-
cedure we chose a background subtraction using the Ideal
mismatch [14], quantile normalization [17], and Tukey's
Biweight [18] method for summarization. Our sample
IDs are as follows: sample A-1 = 1521a99hpp_av06, sam-
ple A-2 = 1532a99hpp_av04, sample A-3 =
2353a99hpp_av08, sample B-1 = 1521b99hpp_av06,
sample B-2 = 1532b99hpp_av04, sample B-3 =
2353b99hpp_av08r.
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